AU476206B2 - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
AU476206B2
AU476206B2 AU84568/75A AU8456875A AU476206B2 AU 476206 B2 AU476206 B2 AU 476206B2 AU 84568/75 A AU84568/75 A AU 84568/75A AU 8456875 A AU8456875 A AU 8456875A AU 476206 B2 AU476206 B2 AU 476206B2
Authority
AU
Australia
Prior art keywords
therapeutic composition
therapeutic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU84568/75A
Other versions
AU8456875A (en
Inventor
POLAK-WYSS and HANS SCHOLER ANNEMARIE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of AU8456875A publication Critical patent/AU8456875A/en
Publication of AU476206B2 publication Critical patent/AU476206B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
AU84568/75A 1974-09-20 1975-09-04 Therapeutic composition Expired AU476206B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CHCH12797/74 1974-09-20
CH1279774 1974-09-20

Publications (2)

Publication Number Publication Date
AU8456875A AU8456875A (en) 1976-09-16
AU476206B2 true AU476206B2 (en) 1976-09-16

Family

ID=4386491

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84568/75A Expired AU476206B2 (en) 1974-09-20 1975-09-04 Therapeutic composition

Country Status (16)

Country Link
AT (1) AT339471B (en)
AU (1) AU476206B2 (en)
BE (1) BE833589A (en)
CU (1) CU34348A (en)
DD (1) DD122023A5 (en)
DE (1) DE2540799A1 (en)
FR (1) FR2285133A1 (en)
GB (1) GB1472046A (en)
HU (1) HU172247B (en)
IE (1) IE41720B1 (en)
IL (1) IL48039A0 (en)
LU (1) LU73422A1 (en)
NL (1) NL7511001A (en)
SE (1) SE7510429L (en)
SU (1) SU607534A3 (en)
ZA (1) ZA755632B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011001091A (en) * 2008-08-01 2011-03-15 Dow Agrosciences Llc Use of 5-fluorocytosine as a fungicide.
CA2776562A1 (en) * 2009-10-07 2011-04-14 Dow Agrosciences Llc Synergistic fungicidal composition containing 5-fluorocytosine for fungal control in cereals

Also Published As

Publication number Publication date
NL7511001A (en) 1976-03-23
IE41720L (en) 1976-03-20
GB1472046A (en) 1977-04-27
IE41720B1 (en) 1980-03-12
AU8456875A (en) 1976-09-16
DE2540799A1 (en) 1976-04-01
LU73422A1 (en) 1977-05-16
AT339471B (en) 1977-10-25
ATA719775A (en) 1977-02-15
IL48039A0 (en) 1975-11-25
SU607534A3 (en) 1978-05-15
FR2285133A1 (en) 1976-04-16
CU34348A (en) 1979-09-08
HU172247B (en) 1978-07-28
DD122023A5 (en) 1976-09-12
ZA755632B (en) 1976-08-25
SE7510429L (en) 1976-03-22
BE833589A (en) 1976-03-19

Similar Documents

Publication Publication Date Title
AU507471B2 (en) Skin composition
AU506178B2 (en) Anaesthetic composition
AU476206B2 (en) Therapeutic composition
AU519636B2 (en) 6-methyl-8alpha-cyanomethylergoline i
CA1022302A (en) Flame-sprayable composition
AU492914B2 (en) Construction composition
AU491193B2 (en) Polyvinylchloride composition
AU8102475A (en) Pharmaceutical composition
AU495749B2 (en) Therapeutic composition
AU8156875A (en) Construction composition
AU485538B2 (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
CA991541A (en) Fungicidal composition
CA1030447A (en) Fungicidal composition
AU489853B2 (en) Fungicidal composition
AU500550B2 (en) Alkanoyltoluene compositions
AU495218B2 (en) Cementiferous compositions
AU482293B2 (en) 7-methoxycephalosporins
AU463759B2 (en) Cyclopentanediones
AU485075B2 (en) 2-nitroimidazoles
AU487545B2 (en) Handstamp
AU489054B2 (en) Thiadiazolylimidazolidones
AU489065B2 (en) B-cyproheptadine-n-oxide
AU489515B2 (en) 1-diaryl-1-OXADIAZOL-ALKYLAMINES
AU488592B2 (en) Tapemeasure
AU488720B2 (en) 2-deutero-3-fluoro-alanine